These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16098319)

  • 1. Major bleeding complications in a specialized anticoagulation service.
    Fanikos J; Grasso-Correnti N; Shah R; Kucher N; Goldhaber SZ
    Am J Cardiol; 2005 Aug; 96(4):595-8. PubMed ID: 16098319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
    Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
    Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin as a marker for bleeding complications during warfarin treatment.
    Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH
    Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
    Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
    Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
    Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
    Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
    Abdelhafiz AH; Wheeldon NM
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends in warfarin-associated hemorrhage.
    Kucher N; Castellanos LR; Quiroz R; Koo S; Fanikos J; Goldhaber SZ
    Am J Cardiol; 2004 Aug; 94(3):403-6. PubMed ID: 15276120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care.
    Aspinall SL; DeSanzo BE; Trilli LE; Good CB
    J Gen Intern Med; 2005 Nov; 20(11):1008-13. PubMed ID: 16307625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
    Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
    Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
    Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
    Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.